Shifting the main purposes of drug control: from suppression to regulation of use: Reduction of risks as the new focus for drug policy |
| |
| Affiliation: | 2. Medical Research Council Unit for Lifelong Health and Ageing at UCL, Department of Population Science and Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK;3. Digital Health Section, European Public Health Association (EUPHA), Utrecht, The Netherlands;4. Association of Schools of Public Health in the European Region (ASPHER), Brussels, Belgium;5. Leibniz Science Campus Digital Public Health Bremen (LSC), Bremen, Germany;6. Research Center on Inequality and Social Policy (socium), Bremen, Germany;7. East London NHS Foundation Trust, London, UK;8. Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, UK;9. Department of International Health, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands;10. Studio Europa, Maastricht University, Maastricht, Netherlands;11. Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy;12. School of Medicine, Vita-Salute San Raffaele University, Milan, Italy;13. Ministry for Health, Malta |
| |
| Abstract: | I believe that the original aims of (almost full) prohibition of substance use, as it is applied according to the NY Single Convention of 1961, are unattainable. Instead, I want to present some arguments and ways of looking at drug use that support a far reaching revision of the current aims of drug control. Drug policy goals should shift, from suppression of use to regulation of use.1 In this article I will present drug use data collected in Amsterdam that in my view support such a shift. Ten years of drug use data in the population of Amsterdam show a remarkable level of control and stability in drug use patterns in a policy environment that allows relatively easy access to drugs. Internal controls on drug use can be expected to play a much larger part in structuring these patterns than classic drug policy theory allows for. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
